Today: 1 May 2026
Yes Bank Q3 profit jumps 55% — provisions slide and CEO flags roadmap, succession
17 January 2026
2 mins read

Yes Bank Q3 profit jumps 55% — provisions slide and CEO flags roadmap, succession

Mumbai, Jan 17, 2026, 15:46 IST

  • Yes Bank reports Q3 FY26 standalone profit at 951.6 crore rupees, with net interest income up 10.9%
  • Provisions and contingencies fall to roughly 22 crore rupees; gross bad-loan ratio tightens to 1.5%
  • CEO announces the bank will unveil a strategic roadmap this quarter; succession planning is already underway

Yes Bank posted a strong jump in quarterly profit on Saturday, driven by a sharp drop in provisions and a modest boost to margins. The CEO announced plans to unveil a strategic roadmap in the next quarter.

The results come at a sensitive time for the Mumbai-based private lender, still working to stabilise earnings following its 2020 bailout and to restore trust in its balance sheet.

Last year, Japan’s Sumitomo Mitsui Banking Corp snapped up a 24% stake, reigniting attention on the turnaround. Kumar’s current term runs out in April, introducing yet another uncertainty.

Standalone net profit jumped to 9.52 billion rupees ($105 million), or 951.6 crore, for the quarter ending Dec. 31, up from 6.12 billion rupees the previous year, according to a filing. Provisions and contingencies dropped sharply to 219 million rupees (around 22 crore) from 2.59 billion rupees (259 crore) a year ago, and down from 4.19 billion rupees (419 crore) in the September quarter.

Net interest income (NII), the difference between interest earned and interest paid, climbed 10.9% to 24.66 billion rupees (2,466 crore), despite a 3.6% drop in interest income to 75.43 billion rupees. The net interest margin, a crucial measure of profitability, ticked up to 2.6% from 2.5% in the previous quarter.

Asset quality remained largely unchanged. Gross non-performing assets, or bad loans, stood at 1.5% of advances at the end of December, down slightly from 1.6% at the end of September, the filing showed. Net bad loans stayed steady at 0.3%.

Loans climbed 5.2% year-on-year, hitting 2.57 trillion rupees (2.57 lakh crore), while deposits edged up 5.5% to roughly 2.93 trillion rupees (2.93 lakh crore). Low-cost CASA deposits — current and savings accounts — jumped 8.5%, pushing the CASA ratio to 34%, according to Upstox.

Non-interest income climbed 8% to 16.33 billion rupees, driven by stronger fee income from cards, loan processing, and third-party distribution, Moneycontrol reported. Operating profit gained 14.3% to 12.34 billion rupees. Stripping out a one-off gratuity provision linked to new labour codes, profit after tax came in at 10.68 billion rupees (1,068 crore), it added.

Chief executive Prashant Kumar described it as a “breakthrough quarter,” highlighting that net credit costs were negligible. During a press call, he mentioned the bank has begun succession planning and plans to unveil a strategic roadmap within the quarter.

Brokerages had forecast a broad range for profits, with many estimates landing between 600 and 780 crore rupees, alongside expected NII growth of 9% to 12%, Business Today reported. Analysts noted that investors often favor larger private banks like HDFC Bank, ICICI Bank, and Axis Bank, citing their more resilient deposit bases.

Much of the profit surge stemmed from a sharp drop in provisions, a boost that could vanish if slippages rise or recoveries falter. Seema Srivastava, senior research analyst at SMC Global Securities, said before the results that “asset quality is expected to remain steady,” which should help keep credit costs in check. https://www.livemint.com/market/stock-mark…

Yes Bank shares closed up 2.2% at 23.45 rupees on Friday, just before the results dropped. The bank joined the Nifty Bank index from Dec. 31, a move likely to attract passive inflows linked to that benchmark.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:15 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Riot Platforms stock jumps on $1 billion AMD data-center lease as investors eye next milestones
Previous Story

Riot Platforms stock jumps on $1 billion AMD data-center lease as investors eye next milestones

Figma stock price sinks near a 52-week low as Wall Street resets targets and insiders sell
Next Story

Figma stock price sinks near a 52-week low as Wall Street resets targets and insiders sell

Go toTop